EUVIMEDEUVIMED entdecken
Crossref

Longitudinal circulating procollagen-markers PRO-C1 and PRO-C2 reflect pubertal growth spurt in healthy adolescents

Li Juel Mortensen iD, Yi He, Martin Blomberg Jensen iD, Jørgen Holm Petersen iD, Hanne Frederiksen iD, Stine Agergaard Holmboe iD, Anne-Christine Bay-Jensen, Anders Juul iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgag203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Li Juel Mortensen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Puberty, Biomarkers, Procollagen, Adolescent Development. Die Arbeit nennt 38 Literaturangaben. Gefördert von: The Kirsten and Freddy Johansen's Foundation, The Danish Medical Research Council, The Research Fund of Rigshospitalet, Copenhagen, Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Epiphyseal growth plate development is stimulated by GH and IGF-I. Serum IGF-I is applied as an efficacy and safety marker, monitoring growth in short GH-treated children. However, IGF-I offers poor guidance to clinicians, especially in children without growth hormone deficiency. Thus, novel biomarkers reflecting endogenous and GH-induced linear growth are needed. We evaluated the association between linear growth during pubertal transition and circulating levels of procollagen type I and II (PRO-C1 and PRO-C2, respectively).

Methods

We included 1700 serum samples from 213 healthy children and adolescents (51% female), ages 5-16 years, from the prospective longitudinal Copenhagen Puberty Study, followed between 2006 and 2014. We assessed peak height velocity (PHV), pubertal development, serum IGF-I, sex steroids (LC-MS/MS), and PRO-C1 and PRO-C2 (immunoassays). Additionally, PRO-C1 and PRO-C2 were determined in short children born small for gestational age before and after 12 months of GH treatment.

Results

Age-, sex-, and puberty-related reference intervals for PRO-C1 and PRO-C2 concentrations were established. PRO-C1 and PRO-C2 increased significantly with age and pubertal development (Tanner breast stage 1-3, P < .0001; Tanner genital stage 1-4, P < .001). During growth spurt, PRO-C1 and PRO-C2 were associated with increased height SD score (SDS) and height velocity, both reached peak concentrations at the time of PHV, earlier than IGF-I and sex-steroids, followed by a rapid decline. In GH-treated prepubertal children, PRO-C1 increased from 0.70 to 3.78 SDS (P < .0001) and PRO-C2 from −2.07 to 0.69 SDS (P = .0055).

Conclusion

We present longitudinal changes in PRO-C1 and PRO-C2 in normal and disordered growth, suggesting PRO-C1 and PRO-C2 as potential biomarkers of endogenous and GH-induced linear growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PubertyBiomarkersProcollagenAdolescent DevelopmentCollagen Type IHumansFemaleAdolescentChildMaleChild, PreschoolLongitudinal StudiesBody HeightHuman Growth HormoneProspective StudiesInsulin-Like Growth Factor I

Stichwörter der Autor:innen

IGF-Igrowth hormonegrowth platepeak height velocitypubertysmall for gestational age

Substanzen

BiomarkersProcollagenHuman Growth HormoneInsulin-Like Growth Factor ICollagen Type I

Autor:innen und Institutionen

  • Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
  • International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
  • Department of Rheumatology, Nordic Bioscience, Biomarkers and Research, Herlev 2730, Denmark.
  • Department of Endocrinology and Internal Medicine, Division of Translational Endocrinology, Copenhagen University Hospital-Herlev and Gentofte, 2730 Herlev, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Section of Biostatistics, Institute of Public Health, Faculty of Health Sciences, University of Copenhagen, 1353 Copenhagen, Denmark.

ORCID-Profile: Li Juel Mortensen, Martin Blomberg Jensen, Jørgen Holm Petersen, Hanne Frederiksen, Stine Agergaard Holmboe, Anders Juul

Förderung

  • The Kirsten and Freddy Johansen's Foundation
  • The Danish Medical Research Council
  • The Research Fund of Rigshospitalet, Copenhagen, Denmark
  • The Lundbeck Foundation
  • Candy's Foundation
  • The Kirsten and Freddy Johansen’s Foundation
  • Candy’s Foundation

Zitieren

APA

Juel Mortensen, L., He, Y., Blomberg Jensen, M., Petersen, J. H., Frederiksen, H., Holmboe, S. A., Bay-Jensen, A. C., & Juul, A. (2026). Longitudinal circulating procollagen-markers PRO-C1 and PRO-C2 reflect pubertal growth spurt in healthy adolescents. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag203

Vancouver

Juel Mortensen L, He Y, Blomberg Jensen M, Petersen JH, Frederiksen H, Holmboe SA, et al. Longitudinal circulating procollagen-markers PRO-C1 and PRO-C2 reflect pubertal growth spurt in healthy adolescents. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag203

BibTeX
@article{JuelMortensen2026,
  author = {Juel Mortensen, Li and He, Yi and Blomberg Jensen, Martin and Petersen, Jørgen Holm and Frederiksen, Hanne and Holmboe, Stine Agergaard and Bay-Jensen, Anne-Christine and Juul, Anders},
  title = {Longitudinal circulating procollagen-markers PRO-C1 and PRO-C2 reflect pubertal growth spurt in healthy adolescents},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag203}
}
Kostenlos starten →